Role of atypical Protein Kinase C in Inflammatory Bowel Disease
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
批准号:
8302661
负责人:
John T Chang
金额:
$33.69万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2017-03-31
关键词:
Adoptive TransferAffectAnimal ModelBacteriaCD4 Positive T LymphocytesCell SeparationCell divisionCellsChronicColitisColonComplexCrohn&aposs diseaseDevelopmentEffector CellFutureImmuneImmune responseImmune systemInflammatory Bowel DiseasesInflammatory disease of the intestineIntestinal DiseasesIntestinesLaboratoriesMediatingMicrobeModelingMusOrganismPathogenesisPathway interactionsProcessProliferatingRecruitment ActivityRoleScienceSideT cell differentiationT-Cell ProliferationT-LymphocyteTestingUlcerative ColitisUnited Statesatypical protein kinase Ccell typedaughter cellinsightmembermicrobialnovelpathogenresponsetrafficking
中文摘要
描述(由申请人提供):炎症性肠病被认为是由遗传易感宿主对共生肠道微生物的不适当免疫反应引起的。先天免疫系统对微生物的异常感知触发致病性T淋巴细胞的发育,从而引发和传播肠道炎症。最近的证据表明,一种被称为不对称细胞分裂的进化保守机制在调节对微生物的适应性免疫反应中发挥了新的作用。在不对称分裂过程中,细胞命运决定因子向分裂面一侧分离,使它们的不平等遗传和子细胞命运分化。我们之前的研究表明,T淋巴细胞似乎经历了不对称分裂,产生了两个不同命运的子细胞(J.T. Chang等人,Science 2007)。此外,我们观察到,保守的非典型PKC (aPKC)-Par3-Par6和Scrib-Dlg-Lgl极性复合物在其他模式生物中调节极性和不对称分裂,在分裂的T细胞中建立互补结构域,这些T细胞被募集到针对微生物病原体的免疫反应中。我们实验室使用结肠炎过继性转移模型的初步证据表明,CD4+ T细胞可能在对共生肠道微生物的失调免疫反应中进行不对称分裂。我们假设极性网络调节激活CD4+ T细胞的不对称分裂,影响其向致病性结肠炎诱导细胞的分化。在本提案中,我们将验证aPKC和Scrib极性复合物调节CD4+ T淋巴细胞进行不对称分裂的能力,分化为致畸Th1和Th17效应细胞,介导肠道炎症的假设。实现这些目标可能会对IBD发病机制的基本机制产生重要的见解,并可能确定未来治疗可能针对的新靶点。
英文摘要
DESCRIPTION (provided by applicant): Inflammatory bowel disease is believed to result from an inappropriate immune response to commensal intestinal microbes in a genetically susceptible host. Aberrant sensing of microbes by the innate immune system triggers the development of pathogenic T lymphocytes that initiate and propagate intestinal inflammation. Recent evidence has suggested a novel role for an evolutionarily conserved mechanism called asymmetric cell division in regulating adaptive immune responses to microbes. During asymmetric division, segregation of cell fate determinants to one side of the plane of division enables their unequal inheritance and the divergence of daughter cell fates. We have previously shown that a T lymphocyte appears to undergo asymmetric division to give rise to two differentially fated daughter cells (J.T. Chang et al., Science 2007). We observed, moreover, that the conserved atypical PKC (aPKC)-Par3-Par6 and Scrib-Dlg-Lgl polarity complexes, which regulate polarity and asymmetric division in other model organisms, establish complementary domains within dividing T cells recruited into an immune response against a microbial pathogen. Preliminary evidence from our laboratory using an adoptive transfer model of colitis suggests that CD4+ T cells may undergo asymmetric division during a dysregulated immune response to commensal intestinal microbes. We hypothesize that the polarity network regulates asymmetric division in activated CD4+ T cells, influencing their differentiation into pathogenic, colitis-inducing cells. In this proposal, we will test the hypothesis that the aPKC and Scrib polarity complexes regulate the ability of CD4+ T lymphocytes to undergo asymmetric division, differentiate into pathogenic Th1 and Th17 effector cells, and mediate intestinal inflammation. Accomplishment of these aims is likely to yield important insights about fundamental mechanisms underlying the pathogenesis of IBD, and could identify new targets against which future therapies might be directed.
PUBLIC HEALTH RELEVANCE: In inflammatory bowel disease, cells of the immune system engage in an aberrant response against intestinal bacteria. This project will investigate the process by which certain immune cells, T lymphocytes, develop into the pathogenic cells that cause intestinal inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell subsets in inflammatory bowel disease
-
批准号:10569030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:John T Chang
-
依托单位:
T cell subsets in inflammatory bowel disease
-
批准号:10364307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10341041
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10008141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10618783
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Project 2 - Chang
-
批准号:10453792
-
项目类别:
-
资助金额:$44.73万
-
财政年份:2018
-
负责人:John T Chang
-
依托单位:
Project 2 - Chang
-
批准号:10214457
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2018
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10025999
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9367846
-
项目类别:
-
资助金额:$3.02万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10308490
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10066260
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10411531
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9753899
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9980269
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9236916
-
项目类别:
-
资助金额:$60.45万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Interrogating adaptive immunity to microbial infection
-
批准号:9138080
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
-
批准号:8448076
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Modulating the Proteasome in Inflammatory Bowel Disease
-
批准号:8436198
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
-
批准号:8637999
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Modulating the Proteasome in Inflammatory Bowel Disease
-
批准号:8223978
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
海外基金